Beam Therapeutics’ Base-Edited CAR-T Placed On Hold

Latest Off-The-Shelf Therapy To Be Delayed

 
• By Andrew McConaghie
  
DNA bases
Beam is a pioneer of a more precise technique in which 'single-letter' editing of DNA and RNA is possible. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip